Pharmaceutical composition for protection from allergies and inflammatory disorders

US9950017B2 · kind B2 · utility

Assignees

• FORSCHUNGSZENTRUM BORSTEL · DE
• RUHR-UNIVERSITÄT BOCHUM · DE

Inventors

• Albrecht Bufe · Darmstadt, DE
• Otto Holst · Bad Oldesloe, DE
• Harald Renz · Marburg, DE
• Erika Von Mutius · Rödental, DE
• Johann Bauer · Ismaning, DE
• Nicole Blumer · Frebershausen, DE
• Jennifer Debarry · Hannover, DE
• Markus Ege · Munich, DE
• Susanne Friedrich · Dortmund, DE
• Holger Garn · Marburg, DE
• Soren Gatermann · Bochum, DE
• Anna Hanuszkiewicz · Siemianowice Śląskie, PL
• Holger Heine · Sülfeld, DE
• Michael Wegmann · Cölbe, DE

Key dates

• Filing date: Mar 3, 2008
• Grant date: Apr 24, 2018
• Expiry date: Jun 12, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.